Amanote Research
Register
Sign In
Genetic Alteration of Metabolism and Tumorigenicity of Prostate Cancer Cells
doi 10.21236/ada417940
Full Text
Open PDF
Abstract
Available in
full text
Date
June 1, 2003
Authors
Pei Feng
Publisher
Defense Technical Information Center
Related search
SULF2 Overexpression Positively Regulates Tumorigenicity of Human Prostate Cancer Cells
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
Genetic Disruption of PPAR Decreases the Tumorigenicity of Human Colon Cancer Cells
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Inactivation of the WASF3 Gene in Prostate Cancer Cells Leads to Suppression of Tumorigenicity and Metastases
British Journal of Cancer
Cancer Research
Oncology
Integrated Proteomic and Glycoproteomic Analyses of Prostate Cancer Cells Reveal Glycoprotein Alteration in Protein Abundance and Glycosylation
Molecular and Cellular Proteomics
Biochemistry
Medicine
Analytical Chemistry
Molecular Biology
Jagged-2 (JAG2) Enhances Tumorigenicity and Chemoresistance of Colorectal Cancer Cells
Oncotarget
Oncology
Molecular Genetic Etiology of Prostate Cancer
The Open Genomics Journal
Genomic Alteration Burden in Advanced Prostate Cancer and Therapeutic Implications
Frontiers in Oncology
Cancer Research
Oncology
Metformin Decreases Glucose Oxidation and Increases the Dependency of Prostate Cancer Cells on Reductive Glutamine Metabolism
Cancer Research
Cancer Research
Oncology
Androgen-Regulated Metabolism and Biosynthesis in Prostate Cancer
Endocrine-Related Cancer
Cancer Research
Endocrinology
Oncology
Metabolism
Diabetes